Selected for FY2024 “Innovation Promotion Project for Achieving Zero Emission Tokyo and Beyond”

　CellAxia Inc. (Headquarters: Chuo-ku, Tokyo; President & CEO: Makoto Seki) is pleased to announce that our “Development of Personalized Cell Therapy Products” has been selected for the Tokyo Metropolitan Government’s FY2024 “Innovation Promotion Project for Achieving Zero Emission Tokyo and Beyond”.

　This program is designed to foster innovative businesses with substantial economic impact and job creation while driving industry revitalization. The Tokyo Metropolitan Government provides partial funding for commercialization and market development activities for breakthrough products developed by venture companies and SMEs through open innovation partnerships with established corporations.

　Through this program, CellAxia will accelerate the clinical development and market introduction of cutting-edge regenerative cell therapy products that offer transformative treatment options for rare diseases and previously untreatable conditions.

For more details on the Tokyo Metropolitan Government’s press release, please visit:
https://www.zeroemiinnovation.metro.tokyo.lg.jp/projects/